GlobeNewswire Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress Provided by GlobeNewswire Nov 14, 2019 1:00 PM UTC
GlobeNewswire Rubius Therapeutics to Participate in Jefferies London Healthcare Conference Provided by GlobeNewswire Nov 12, 2019 9:05 PM UTC
GlobeNewswire Rubius Therapeutics Appoints Maiken Keson-Brookes as Chief Legal Officer and Corporate Secretary Provided by GlobeNewswire Nov 12, 2019 1:00 PM UTC
GlobeNewswire Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Provided by GlobeNewswire Nov 8, 2019 12:00 PM UTC
GlobeNewswire Rubius Therapeutics to Announce Third Quarter 2019 Financial Results Provided by GlobeNewswire Nov 5, 2019 9:05 PM UTC
PR Newswire Entrada Therapeutics Appoints Nathan Dowden as Chief Operating Officer Provided by PR Newswire Nov 4, 2019 1:00 PM UTC
GlobeNewswire Rubius Therapeutics Announces Oncology Poster Presentations at Upcoming Medical Conferences Provided by GlobeNewswire Oct 17, 2019 12:00 PM UTC